Abstract
Nanoscience deals with the study of materials at nanoscale dimensions. It
has been shown that modernizing drugs to a nanosized delivery system will afford
fruitful outcomes with enhanced efficacy against the virus, reduction of the drug dose
and improved targetability with enhanced/sustained bioavailability, If the drug dose is
reduced, the dose-related side effects are reduced. Dose reduction through
nanotechnology also limits non-target tissue toxicity. Hence, nanotechnology has
remarkable potential in the pharmaceutical industry. Due to their small molecular level
of tunable size, nanopharmaceuticals (in the form of nanoparticles) will easily enter the
cells or tissues. The case of COVID-19, they interact with the virus and act accordingly
and might inhibit the viral processes of 2019nCoV in COVID-19.
Keywords: Active targeting, COVID-19, Gold NPs, Macrophage-targeting, Nanohybrids, Nanoparticles, Nanotechnology, Nb11-59, PLGA NPs.
Related Journals
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents